© 2022 Sema4 OpCo, Inc. All rights reserved.
hero-ecs-consumers-001-2019-june-21
Category: hero
hero-oncology-page-2019-001-may-31
hero-hereditary-page-2019-001-may-31
hero-2019-asco-annual-meeting-001
hero-home-new-001-unlocking-answers-to-your-health
hero-noninvasive-prenatal-select
Meaningful insights into your baby’s health
Sema4 Noninvasive Prenatal Select is a simple blood test that can detect chromosomal abnormalities as early as 9 weeks into pregnancy
hero-solid-tumor-panel-001-solid-tumor-panel
Actionable insights into solid tumor cancers
Sema4 Solid Tumor Panel analyzes 161 of the most relevant cancer driver genes to help doctors find the right treatment, the first time
hero-test-catalog-001-headline-goes-here
Test Catalog
Our comprehensive offering of genetic tests
With state-of-the-art technology, high detection rates, and an unparalleled service model, our lab provides simple and accurate genetic and genomic screening. Our testing catalog includes molecular, cytogenetic, and biochemical analyses, allowing for the accommodation of even the most unique of cases.
hero-for-oncology-001-helping-doctors-find-the-right-drug
The Oncology Hotspot Panel
Helping doctors find the right treatment, the first time
The Oncology Hotspot Panel analyzes 207 regions of the genome to deliver powerful insights about the unique genetic profile of each tumor.
hero-partnerships-001-more-than-just-a-test
More Than Just a Test.
Sema4 merges data and science to help our partners identify, target and validate novel predictive and prognostic biomarkers.
Through our unique data, tools, interrogation, predictive models, and expertise we are improving outcomes for our partners, such as Janssen.
